Mice lacking serum amyloid P component do not necessarily develop severe autoimmune disease

被引:15
作者
Soma, M
Tamaoki, T
Kawano, H
Ito, S
Sakamoto, M
Okada, Y
Ozaki, Y
Kanba, S
Hamada, Y
Ishihara, T
Maeda, S
机构
[1] Yamanashi Med Univ, Dept Biochem 1, Yamanashi 4093898, Japan
[2] Yamanashi Med Univ, Dept Orthopaed Surg, Yamanashi 4093898, Japan
[3] Yamanashi Med Univ, Dept Neuropsychiat, Yamanashi 4093898, Japan
[4] Yamanashi Med Univ, Dept Clin & Lab Med, Yamanashi 4093898, Japan
[5] Yamaguchi Univ, Sch Med, Dept Pathol 1, Ube, Yamaguchi 755, Japan
关键词
acute-phase reaction; autoimmune response; endotoxic shock; knockout mouse; pentraxin; serum amyloid P component;
D O I
10.1006/bbrc.2001.5364
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serum amyloid P component (SAP) is a major acute-phase reactant in mice. Recently, it was reported that SAP-deficient mice spontaneously developed antinuclear antibodies and severe glomerulonephritis. Because the SA-P-deficient mice we generated display no obvious phenotypic abnormalities, we investigated whether our SAP-deficient mice would also spontaneously develop autoimmune responses. In accordance with the report, our mice produced high titers of antinuclear antibody but did not develop severe glomerulonephritis. On the other hand, it was recently reported that SAP bound to gram-negative bacteria via lipopolysaccharide (LPS) prevented LPS-mediated activation of a classical complement pathway. Thus, we asked if SAP-deficient mice would show altered responses to an intraperitoneal injection of LPS from Salmonella typhimirium. SAP-deficiency did afford resistance to lethality induced by high-dose LPS. Our experiments clearly showed that contrary to documented data, SAP-deficient mice do not develop serious autoimmune disease and we suggest that SAP has a critical role in LPS toxicity. (C) 2001 Academic Press.
引用
收藏
页码:200 / 205
页数:6
相关论文
共 23 条
  • [1] SPONTANEOUS MURINE LUPUS-LIKE SYNDROMES - CLINICAL AND IMMUNOPATHOLOGICAL MANIFESTATIONS IN SEVERAL STRAINS
    ANDREWS, BS
    EISENBERG, RA
    THEOFILOPOULOS, AN
    IZUI, S
    WILSON, CB
    MCCONAHEY, PJ
    MURPHY, ED
    ROTHS, JB
    DIXON, FJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1978, 148 (05) : 1198 - 1215
  • [2] Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity
    Bickerstaff, MCM
    Botto, M
    Hutchinson, WL
    Herbert, J
    Tennent, GA
    Bybee, A
    Mitchell, DA
    Cook, HT
    Butler, PJG
    Walport, MJ
    Pepys, MB
    [J]. NATURE MEDICINE, 1999, 5 (06) : 694 - 697
  • [3] Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene
    Botto, M
    Hawkins, PN
    Bickerstaff, MCM
    Herbert, J
    Bygrave, AE
    McBride, A
    Hutchinson, WL
    Tennent, GA
    Walport, MJ
    Pepys, MB
    [J]. NATURE MEDICINE, 1997, 3 (08) : 855 - 859
  • [4] ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE
    CHIRGWIN, JM
    PRZYBYLA, AE
    MACDONALD, RJ
    RUTTER, WJ
    [J]. BIOCHEMISTRY, 1979, 18 (24) : 5294 - 5299
  • [5] de Haas CJC, 1998, J IMMUNOL, V161, P3607
  • [6] Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation
    de Haas, CJC
    van Leeuwen, EMM
    van Bommel, T
    Verhoef, J
    van Kessel, KPM
    van Strijp, JAG
    [J]. INFECTION AND IMMUNITY, 2000, 68 (04) : 1753 - 1759
  • [7] New insights into the role of serum amyloid P component, a novel lipopolysaccharide-binding protein
    de Haas, CJC
    [J]. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 1999, 26 (3-4): : 197 - 202
  • [8] STRUCTURE AND FUNCTION OF THE PENTRAXINS
    GEWURZ, H
    ZHANG, XH
    LINT, TF
    [J]. CURRENT OPINION IN IMMUNOLOGY, 1995, 7 (01) : 54 - 64
  • [9] Kelly MA, 1998, J NEUROSCI, V18, P3470
  • [10] ACUTE-PHASE RESPONSE OF MESSENGER-RNAS FOR SERUM AMYLOID P-COMPONENT, C-REACTIVE PROTEIN AND PREALBUMIN (TRANSTHYRETIN) IN MOUSE-LIVER
    MURAKAMI, T
    OHNISHI, S
    NISHIGUCHI, S
    MAEDA, S
    ARAKI, S
    SHIMADA, K
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 155 (02) : 554 - 560